Physician profile
Dennis J Teehan
NPI 1306006945
$7,533.95
in general payments reported to CMS, 2019-2025
36 companies · $2,109 in 2025
The $2,109 reported for 2025 was more than what 88% of Preventive Medicine/Occupational Environmental Medicine providers received nationally (typical 2025 total: $76.00).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,048 · 2020: $192 · 2021: $115 · 2022: $204 · 2023: $1,703 · 2024: $2,163 · 2025: $2,109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,976.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,975.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $1,654.14 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Abbvie INC. | $879.89 | 2021-2025 | Qulipta, Ubrelvy, Vraylar |
| Lilly USA, LLC | $748.55 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Pfizer INC. | $705.52 | 2019-2025 | |
| Amgen INC. | $595.16 | 2019-2025 | Repatha, Evenity, Otezla |
| Novartis Pharmaceuticals Corporation | $520.23 | 2019-2025 | |
| Novo Nordisk INC | $451.44 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Antares Pharma, INC. | $286.32 | 2019-2025 | Xyosted, Nocdurna, Tlando |
| Bayer Healthcare Pharmaceuticals INC. | $249.74 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $133.85 | 2019-2020 | |
| Esperion Therapeutics, INC. | $123.48 | 2023-2025 | Nexletol |
| Tolmar, INC. | $97.83 | 2023-2024 | |
| Endo Pharmaceuticals INC. | $97.00 | 2019-2021 | |
| Celgene Corporation | $96.14 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $86.30 | 2024-2025 | Jardiance |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $79.58 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Halozyme INC | $77.67 | 2023 | |
| Seqirus USA INC | $69.52 | 2023-2025 | Fluad, Flucelvax, Fluad Quadrivalent |
| Janssen Pharmaceuticals, INC | $60.05 | 2020-2024 | Xarelto |
| Sanofi Pasteur INC. | $55.94 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $55.91 | 2019-2025 | Gardasil 9, M-M-R II, Capvaxive |
| Medtronic, INC. | $55.84 | 2024 | Minimed 780g |
| Kowa Pharmaceuticals America, INC. | $48.72 | 2025 | Zoryve |
| Biogen, INC. | $40.32 | 2024-2025 | Leqembi |
| Eisai INC. | $38.44 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $38.17 | 2019 | |
| Neurocrine Biosciences, INC. | $28.38 | 2023 | Ingrezza |
| Ultragenyx Pharmaceutical INC. | $24.89 | 2025 | Dojolvi |
| Echosens North America, INC. | $22.72 | 2024-2025 | Fibroscan, Fibroscan |
| Biohaven Pharmaceuticals, INC. | $20.77 | 2021 | |
| Rgh Enterprises LLC | $17.48 | 2025 | |
| Hologic Sales and Service, LLC | $17.30 | 2025 | Aptima, Thinprep 2000 Processor |
| Allergan, INC. | $16.38 | 2020 | |
| Dynavax Technologies Corporation | $14.87 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.15 | 2019 | |
| Acerus Pharmaceuticals Corporation | $12.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Teehan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.